) Prostate Cancer is the most common cancer in U.S. men. The disease has a unique association with ethnic background - the highest incidence and mortality risk in African Americans, an intermediate risk in European-Americans, and a significantly lower risk among Hispanics, notably Mexican Americans who constitute the largest proportion of Hispanics in the U.S. A number of hypotheses may explain these differences including dietary factors, micronutrient use, and genetic differences - especially those that modify the response of the androgen receptor. This program, the San Antonio Center of Biomarkers of Risk for prostate cancer (SABOR) will leverage the collaboration of five institutions with access to large numbers of ethnic minorities to conduct serial examinations for prostate cancer, examine biomarkers of risk and outcome, and to link these data with an extensive, robust clinical database. Specific biomarkers to be examined include IGF-1, IGFBP-3 and -4, androgen receptor trinucleotide repeat length, as well as nutritional analyses and selenium exposure. This ethnically-diverse population, the biorepository, and clinical database system will focus upon those unique factors of prostate cancer risk and will bring these unique and valuable resources to the network of investigators in the Early Detection Research Network.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project--Cooperative Agreements (U01)
Project #
1U01CA086402-01
Application #
6133868
Study Section
Special Emphasis Panel (ZCA1-SRRB-Y (J1))
Program Officer
Srivastava, Sudhir
Project Start
2000-05-15
Project End
2005-02-28
Budget Start
2000-05-15
Budget End
2001-02-28
Support Year
1
Fiscal Year
2000
Total Cost
$534,407
Indirect Cost
Name
University of Texas Health Science Center San Antonio
Department
Urology
Type
Schools of Medicine
DUNS #
800772162
City
San Antonio
State
TX
Country
United States
Zip Code
78229
Ankerst, Donna P; Goros, Martin; Tomlins, Scott A et al. (2018) Incorporation of Urinary Prostate Cancer Antigen 3 and TMPRSS2:ERG into Prostate Cancer Prevention Trial Risk Calculator. Eur Urol Focus :
Yu, Ming; Maden, Sean K; Stachler, Matthew et al. (2018) Subtypes of Barrett's oesophagus and oesophageal adenocarcinoma based on genome-wide methylation analysis. Gut :
Shi, Tujin; Quek, Sue-Ing; Gao, Yuqian et al. (2017) Multiplexed targeted mass spectrometry assays for prostate cancer-associated urinary proteins. Oncotarget 8:101887-101898
Luebeck, E Georg; Curtius, Kit; Hazelton, William D et al. (2017) Identification of a key role of widespread epigenetic drift in Barrett's esophagus and esophageal adenocarcinoma. Clin Epigenetics 9:113
Long Parma, Dorothy; Muñoz, Edgar; Ogden, Susan M et al. (2017) Helicobacter Pylori Infection in Texas Hispanic and Non-Hispanic White Men: Implications for Gastric Cancer Risk Disparities. Am J Mens Health 11:1039-1045
Conti, David V; Wang, Kan; Sheng, Xin et al. (2017) Two Novel Susceptibility Loci for Prostate Cancer in Men of African Ancestry. J Natl Cancer Inst 109:
Macleod, Liam C; Ellis, William J; Newcomb, Lisa F et al. (2017) Timing of Adverse Prostate Cancer Reclassification on First Surveillance Biopsy: Results from the Canary Prostate Cancer Active Surveillance Study. J Urol 197:1026-1033
Liss, M A; Schenk, J M; Faino, A V et al. (2016) A diagnosis of prostate cancer and pursuit of active surveillance is not followed by weight loss: potential for a teachable moment. Prostate Cancer Prostatic Dis 19:390-394
Chen, Haitao; Liu, Xu; Brendler, Charles B et al. (2016) Adding genetic risk score to family history identifies twice as many high-risk men for prostate cancer: Results from the prostate cancer prevention trial. Prostate 76:1120-9
Ankerst, Donna Pauler; Gelfond, Jonathan; Goros, Martin et al. (2016) Serial Percent Free Prostate Specific Antigen in Combination with Prostate Specific Antigen for Population Based Early Detection of Prostate Cancer. J Urol 196:355-60

Showing the most recent 10 out of 149 publications